Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
Evaluation of three aflibercept injections at 4-week intervals in patients with neovascular AMD showing an “insufficient anatomic response” to prior anti-VEGF therapy with ranibizumab or bevacizumab.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
11 March 2014
|
| In: |
Graefe's archive for clinical and experimental ophthalmology
Year: 2014, Volume: 252, Issue: 11, Pages: 1705-1709 |
| ISSN: | 1435-702X |
| DOI: | 10.1007/s00417-014-2589-3 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00417-014-2589-3
|
| Author Notes: | Heidi Fassnacht-Riederle, Matthias Becker, Nicole Graf, Stephan Michels |
| Summary: | Evaluation of three aflibercept injections at 4-week intervals in patients with neovascular AMD showing an “insufficient anatomic response” to prior anti-VEGF therapy with ranibizumab or bevacizumab. |
|---|---|
| Item Description: | Gesehen am 22.09.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1435-702X |
| DOI: | 10.1007/s00417-014-2589-3 |